Xiaojing Gao (@SynBioGaoLab) profile picture

Assistant Professor @ Stanford ChemE synthetic biology, biomolecular engineering https://www.teapawt.org/t.co/KAajKt7YdT

Stanford, CA
Joined June 2019
Photo by Xiaojing Gao (@SynBioGaoLab)Photo by Xiaojing Gao (@SynBioGaoLab)Photo by Xiaojing Gao (@SynBioGaoLab)Photo by Xiaojing Gao (@SynBioGaoLab)
Help! I need philanthropists to help Impetus Grants produce the missing data AI needs to ACTUALLY cure diseases of aging. There’s a lot of talk about simulation solving biology. Useful simulations don’t come out of thin air: DeepMind’s latest weather prediction model was trained on weather records dating back to 1959. AlphaFold had decades of PDB. Tesla and Waymo’s driving simulations draw on data collected over tens of millions of miles on real roads. Building the biological equivalent requires a much stronger data foundation. We need more observations of how diseases with long timelines like Alzheimer’s unfold and respond to treatments. Some of those observations will take years no matter how fast intelligence improves. So I’m directing @impetusgrants to identify longitudinal biosamples we can use for AI-quality data generation, as well as starting necessary new cohorts today. I started @impetusgrants in 2021 after hearing @patrickc talk about Fast Grants at a conference. If fast grants worked for COVID, why not longevity? COVID was obviously urgent. But far more people die from age-related diseases. Since then we’ve deployed $34M across 146 projects and supported five clinical trials, with resulting publications 100x representation in Nature/Science/Cell About 60% of the papers we assessed had no National Institute on Aging support identified. Very satisfying to see work we funded a few years ago now bearing fruit: norn.group/impetus-grants The next round will fund around 50 projects generating open source data on how diseases of aging develop and respond to treatments. We’ve raised >$9M toward the $15M we need to kick off. If you’d like to help fund this or know someone who could, please DM me. (No fancy video of rockets and art deco, all our money goes to longevity research)
9
38
8
85
6,478
Xiaojing Gao retweeted
In new work, we report a surprising finding: prompting Evo 2 with a handful of sequences of shared function can steer the model to generate new sequences with similar function, a form of generative in-context learning (ICL). This is an emergent phenomenon that we did not anticipate during training. In a first study, led by Alex Hao, we show that ICL enables few-shot design of mammalian regulatory elements, including novel enhancers with cell-type specificity for a neuronal subtype in the mouse brain. In a second study, led by @garykbrixi and Alex Hao, we extend these results to the computational design of natural proteins, de novo antibodies, protein-RNA systems, and complete bacteriophage genomes. As part of this work, we also release several useful new artifacts, including a highly efficient new inference stack. 1/n
18
63
6
278
21,108
Xiaojing Gao retweeted
Regulatable in vivo gene expression via adaptamers sciencedirect.com/science/ar…
1
11
1
69
5,200
Xiaojing Gao retweeted
As with biological design, AI can also accelerate biological discovery. In new work led by @_David_Li and @garykbrixi with @mfgrp, we show how genome language models enable systematic discovery of genetic elements, revealing a new class of reverse-transcriptase mechanisms.
4
61
7
343
33,232
Efficient generation of epitope-targeted antibodies with Germinal - @BrianHie @SynBioGaoLab nature.com/articles/s41587-0…
2
30
157
13,872
Nifty work on plasmid chromatinization from @stergachislab ! "plasmids are indeed capable of recapitulating nuclear genome-encoded chromatin architectures, ... However, plasmids consistently adopt a heterogeneous and incomplete chromatin architecture relative to nuclear-encoded chromatin fibers, and surrounding sequence context plays an integral role in modulating whether a plasmid-encoded regulatory element will recapitulate nuclear genome-encoded chromatin architectures."
Online Now: Chromatin architectures underlying plasmid-based assays for regulatory variant effects dlvr.it/TSkLhj
19
34
10,553
Xiaojing Gao retweeted
I have long written and spoken about the many ways US immigration policy harms international students and scholars. This has been true for as long as I can remember, including when I first came to the US on a single-entry student visa more than 20 years ago under a process formerly known as muslim registry program. But the current administration has gone much further, through arbitrary policy changes, travel bans, and broad visa processing pauses that leave folks unable to work, travel, or train. These policies affect a minority of scientists, and in the current state of the world they can be easy to overlook. But we should not let that happen. I wrote about the quiet loss of Iranian scientific talent in US labs for @TheScientistLLC: the-scientist.com/the-quiet-…
320
107
33
481
281,170
qPCR allowed us to measure transcripts, but just once, destructively, and only in post-mortem tissues. Here, we show we can record transcript level history in vivo and recover this information with a blood test to make a "noninvasive qPCR". nature.com/articles/s41467-0…
3
37
2
149
14,783
Xiaojing Gao retweeted
Replying to @Doudna_lab
This is not real.
1
2
19
10,589
Xiaojing Gao retweeted
Excited to report the first de novo enzyme catalyzing two of the most energetically demanding reactions in biology—phosphomonoester and phosphodiester hydrolysis—with catalytic efficiencies comparable to natural enzymes! 🚀 desB was designed zero-shot with dEVA. No structure prediction, no pre-defined motif, no reaction-intermediates. 🧵 @StanfordBiosci @bioe_stanford @SLAClab @EPFL @hes_so @simonduerr
2
62
4
280
25,493
Xiaojing Gao retweeted
Could the folding of synthetic gene circuits in 3D shape how genes are expressed? Today @ScienceMagazine we report on the role of gene syntax in shaping feedback between transcriptional activity and genome folding for advanced circuit design🧵 (1/n)
23
187
14
690
73,564
So you want to engineer your hiPSCs, but targeting DNA payloads requires multiple slow, inefficient steps for each construct. What if we could accomplish multi-site integration seamlessly? Come hear about STRAIGHT-IN Dual now out at Nature Biomedical Engineering! 🧵 Link at end!
3
41
6
153
16,333
Xiaojing Gao retweeted
So excited that our work on Programmable Macromolecule Delivery via Engineered Trogocytosis is out in @NatureCellBio! Link: rdcu.be/fa90i @stanleyqilab @Stanford_ChEMH @bioe_stanford @StanfordBioX A 🧵on our story:
3
8
1
33
5,348
Engineering the next frontier of mammalian systems. Accepting abstracts through April 15 - submit yours now: bit.ly/4jQmrFj #mSBW2026 #SyntheticBiology #MammalianSystems #CallForAbstracts
2
1
8
690
Xiaojing Gao retweeted
Important paper from Jason Chin's and Julian Sale's labs realizing key operations needed for building synthetic human genomes. My repeated reaction reading this paper was "um, I didn't know you could just do that." science.org/doi/abs/10.1126/…
3
29
3
131
17,815
Xiaojing Gao retweeted
Thrilled to share our new paper in Cell! We show that phase separation can buffer growth-mediated dilution in synthetic circuits by stabilizing gene expression under dynamic conditions, bringing spatial control into the genetic design toolbox Proud of our amazing team & collaborators! cell.com/cell/fulltext/S0092…
2
6
19
1,554
Xiaojing Gao retweeted
I am delighted to share this work, led by Miguel Alcantar and done in collaboration with Amgen, on the OrthoRep-driven evolution of computationally designed minibinders. Here, we focus not only on getting to high affinity, but also on mapping sequence-affinity landscapes of diverse evolutionary outcomes. One way we arrive at diverse evolutionary outcomes is through "neutral drift" where we take one binder and diverge it into many by selecting for the maintenance of (but not improvement of) binding. This is very easy to do with OrthoRep because rapid mutation of the binder occurs autonomously. The result is a rich sequence-affinity dataset spanning both a range of sequences and affinities. We are now scaling these approaches, including to antibodies and a broad array of targets, to get the right distribution and volume of data for training generative models for binder design. biorxiv.org/content/10.1101/…
2
21
2
116
13,729